Briefs

NEW YORK, Feb. 6 - AnVil will analyze lung tumors for the National Cancer Institute in an attempt to find gene markers for lung cancer diagnostics and treatments, the company said recently.

AnVil, a data management and visualization company based in Burlington, Mass., will use its technologies to explore NCI gene-expression data to help it determine which genes may be linked to lung tumors or normal lung tissue.

See www.anvilinfo.com